Psychological symptoms and disease-free and overall survival in women with stage II breast cancer

Journal of the National Cancer Institute

Volumn 88, Issue 10, 1996, Pages 661-667

  Tross, Susan ^a   Herndon II, James ^b   Korzun, Ann ^c   Kornblith, Alice B ^d   Cella, David F ^e   Holland, James F ^f   Raich, Peter ^g   Johnson, Anita ^h   Kiang, David T ⁱ   Perloff, Marjorie ^j   Norton, Larry ^d   Wood, William ^k   Holland, Jimmie C ^d  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e Rush Presbylerian St Lukes Med C   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g WEST VIRGINIA UNIVERSITY   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF MINNESOTA   (United States)

^j NATIONAL CANCER INSTITUTE   (United States)

^k EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; FLUOXYMESTERONE; METHOTREXATE; PREDNISONE; THIOTEPA; VINBLASTINE; VINCRISTINE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENTAL STRESS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RISK; STRESS, PSYCHOLOGICAL; SURVIVAL ANALYSIS;

EID: 15844378210     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.10.661     Document Type: Article

References (33)

1. Greer S, Morris T. The study of psychological factors in breast cancer: problems of method. Soc Sci Med 1978;12:129-34.
2. Ramirez AJ, Craig TK, Watson JP, Fentiman IS, North WR, Rubens RD. Stress and relapse of breast cancer [see comment citations in Medline]. Br Med J 1989;298:291-3.
3. Marshall JR, Funch DP. Social environment and breast cancer. A cohort analysis of patient survival. Cancer 1983;52:1546-50.
4. Cassileth BR, Lusk EJ, Miller DS, Brown LL, Miller C. Psychological correlates of survival in advanced malignant disease? N Engl J Med 1985;312:1551-5.
5. Jamison RN, Burish TG, Wallston KA. Psychogenic factors in predicting survival of breast cancer patients. J Clin Oncol 1987;5: 768-72.
6. Silberfarb PM, Anderson KM, Rundle AC, Holland JC, Cooper MR, McIntyre OR. Mood and clinical status in patients with multiple myeloma. J Clin Oncol 1991;9:2219-24.
7. Barraclough J, Pinder P, Cruddas M, Osmond C, Taylor I, Perry M. Life events and breast cancer prognosis [see comment citations in Medline]. Br Med J 1992;304:1078-81.
8. Persky VW, Kempthorne-Rawson J, Shekelle RB. Personality and risk of cancer: 20-year follow-up of the Western Electric Study. Psychosom Med 1987;49:435-49.
9. Fox B. The role of psychological factors in cancer incidence and prognosis. Oncology 1995;9:245-53.
10. Greer S, Morris T, Pettingale KW. Psychological response to breast cancer: effect on outcome. Lancet 1979;2:785-7.
11. Hislop TG, Waxier NE, Coldman AJ, Elwood JM, Kan L. The prognostic significance of psychosocial factors in women with breast cancer. J Chronic Dis 1987;40:729-35.
12. Buddeberg C, Wolf C, Sieber M, Riehl-Emde A, Bergant A, Steiner R, et al. Coping strategies and course of disease of breast cancer patients. Results of a 3-year longitudinal study. Psychother Psychosom 1991;55:151-7.
13. Derogatis LR, Abeloff MD, Melisaratos N. Psychological coping mechanisms and survival time in metastatic breast cancer. JAMA 1979;242:1504-8.
14. Temoshok L. Personality, coping style, emotion and cancer: towards an integrative model. Cancer Surv 1987;6:545-67.
15. Kreitler S, Chaitchik S, Kreitler H. Repressiveness: cause or result of cancer? Psycho-oncology 1993;2:43-54.
16. Perloff M, Norton L, Korzun A, Wood W, Carey R, Weinberg V, et al. Advantage of Adriamycin (A) plus Halotestin (H) after initial cyclophosphamide, methotrexate. 5-fluorouracil, vincristine, and prednisone (CMFVP) for adjuvant therapy of node-positive stage II breast cancer. Proc ASCO 1986;5:70.
17. Perloff M, Norton L, Korzun A, Wood W, Carey R, Gottlieb A, et al. Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a noncross-resistant regimen: a CALGB study. J Clin Oncol. In press.
18. Derogatis LR, The SCL-90 manual I: scoring, administration, and procedures for the SCL-90. Baltimore (MD): Clinical Psychometric Research, 1977.
19. Derogatis LR, Cleary PA. Confirmation of the dimensional structure of the SCL-90: a study in construct validation. J Clin Psychol 1977; 33:981-9.
20. Derogatis LR, Spencer PM. The Brief Symptom Inventory (BSI): administration, scoring and procedures manual. Baltimore: Johns Hopkins University School of Medicine, 1982.
21. Zubrod CG, Schneiderman M, Frei E 3d, Brindley C, Gold GL, Shnider B, et al. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis 1960;11:7-33.
22. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
23. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50: 163-70.
24. Cox DR. Regression models and life tables. J R Stat Soc Series B 1972;34:187-220.
25. Cella DF, Orav EJ, Kornblith AB, Holland JC, Silberfarb PM, Lee KW, et al. Socioeconomic status and survival. J Clin Oncol 1991;9:1500-9.
26. Fox B. Current theory of psychogenic effects on cancer incidence and prognosis. J Psychosoc Oncol 1983;1:17-31.
27. Redd WH, Silberfarb PM, Andersen BL, Andrykowski MA, Bovbjerg DH, Burish TG, et al. Physiologic and psychobehavioral research in oncology. Cancer 1991;67(3 Suppl): 813-22.
28. Spiegel D. Psychosocial aspects of cancer. Curr Opin Psychiatry 1991;4:889-97.
29. Coates A, Gebski V, Signorini D, Murray P, McNeil D, Byrne M, et al. Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group [see comment citation in Medline]. J Clin Oncol 1992; 10:1827-9.
30. Ruckdeschel S, Piantadosi S, and the Lung Cancer Study Group. Quality-of-life assessment in lung surgery for bronchogenic carcinoma. Theor Surg 1991;6:201-5.
31. Spiegel D, Bloom JR, Kraemer HC, Gottheil E. Effect of psychosocial treatment on survival of patients with metasiatic breast cancer [see comment citation in Medline]. Lancet 1989;2: 888-91.
32. Fawzy FI, Fawzy NW, Hyun CS, Elashoff R, Guthrie D, Fahey JL, et al. Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 1993;50:681-9.
33. Richardson JL, Shelton DR, Krailo M, Levine AM. The effect of compliance with treatment on survival among patients with hematologic malignancies J Clin Oncol 1990;8:356-64.